Evoke Pharma (EVOK) Tops Q3 EPS by 12c

Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.42), $0.12 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
• Wall Street scrambles to lift Micron price targets ahead of earnings